Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Emerging Targets and Latest Proteomics Based Therapeutic Approaches in Neurodegenerative Diseases.

Fatima MT, Islam Z, Ahmad E, Salahuddin P.

Curr Protein Pept Sci. 2018;19(9):858-875. doi: 10.2174/1389203718666170731114757. Review.

PMID:
28762306
2.

Walking the tightrope: proteostasis and neurodegenerative disease.

Yerbury JJ, Ooi L, Dillin A, Saunders DN, Hatters DM, Beart PM, Cashman NR, Wilson MR, Ecroyd H.

J Neurochem. 2016 May;137(4):489-505. doi: 10.1111/jnc.13575. Epub 2016 Mar 8. Review.

3.

[Immunotherapy targeting misfolded proteins in neurodegenerative disease].

Kanemaru K.

Brain Nerve. 2013 Apr;65(4):469-74. Review. Japanese.

PMID:
23568995
4.

Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.

Ciechanover A, Kwon YT.

Exp Mol Med. 2015 Mar 13;47:e147. doi: 10.1038/emm.2014.117. Review.

5.

Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review.

Khanam H, Ali A, Asif M, Shamsuzzaman.

Eur J Med Chem. 2016 Nov 29;124:1121-1141. doi: 10.1016/j.ejmech.2016.08.006. Epub 2016 Aug 6. Review.

PMID:
27597727
6.

Molecular Chaperones in Neurodegenerative Diseases: A Short Review.

Bobori C, Theocharopoulou G, Vlamos P.

Adv Exp Med Biol. 2017;987:219-231. doi: 10.1007/978-3-319-57379-3_20. Review.

PMID:
28971461
7.

Role of molecular chaperones in neurodegenerative disorders.

Meriin AB, Sherman MY.

Int J Hyperthermia. 2005 Aug;21(5):403-19. Review.

PMID:
16048838
8.

Aggregopathy in neurodegenerative diseases: mechanisms and therapeutic implication.

Dohm CP, Kermer P, Bähr M.

Neurodegener Dis. 2008;5(6):321-38. doi: 10.1159/000119459. Epub 2008 Feb 29. Review.

PMID:
18309232
9.

Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders.

Bose S, Cho J.

Ageing Res Rev. 2017 May;35:155-175. doi: 10.1016/j.arr.2016.09.004. Epub 2016 Oct 1. Review.

PMID:
27702699
10.

Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.

Hekmatimoghaddam S, Zare-Khormizi MR, Pourrajab F.

Biofactors. 2017 Nov;43(6):737-759. doi: 10.1002/biof.1264. Epub 2016 Feb 22. Review.

PMID:
26899445
11.

Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.

Maiti P, Manna J, Veleri S, Frautschy S.

Biomed Res Int. 2014;2014:495091. doi: 10.1155/2014/495091. Epub 2014 Oct 19. Review.

12.

Protein-misfolding diseases and chaperone-based therapeutic approaches.

Chaudhuri TK, Paul S.

FEBS J. 2006 Apr;273(7):1331-49. Review.

13.

Proteostasis and the Regulation of Intra- and Extracellular Protein Aggregation by ATP-Independent Molecular Chaperones: Lens α-Crystallins and Milk Caseins.

Carver JA, Ecroyd H, Truscott RJW, Thorn DC, Holt C.

Acc Chem Res. 2018 Mar 20;51(3):745-752. doi: 10.1021/acs.accounts.7b00250. Epub 2018 Feb 14. Review.

PMID:
29442498
14.
16.

Quality control of the proteins associated with neurodegenerative diseases.

Gao X, Hu H.

Acta Biochim Biophys Sin (Shanghai). 2008 Jul;40(7):612-8. Review.

17.

[Molecular therapy targeting protein misfolding and aggregation for the polyglutamine diseases].

Nagai Y.

Rinsho Shinkeigaku. 2009 Nov;49(11):913-6. Review. Japanese.

PMID:
20030247
18.

Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins.

Naeem A, Fazili NA.

Cell Biochem Biophys. 2011 Nov;61(2):237-50. doi: 10.1007/s12013-011-9200-x. Review.

PMID:
21573992
19.
20.

Biological and chemical approaches to diseases of proteostasis deficiency.

Powers ET, Morimoto RI, Dillin A, Kelly JW, Balch WE.

Annu Rev Biochem. 2009;78:959-91. doi: 10.1146/annurev.biochem.052308.114844. Review.

PMID:
19298183

Supplemental Content

Support Center